Global Small Animals Respiratory Diseases Treatment Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Small Animals Respiratory Diseases Treatment Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Anthelmintics
- 1.4.3 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
- 1.4.4 Corticosteroids
- 1.4.5 Antibiotics
- 1.4.6 Antihistamines
- 1.4.7 Phosphodiesterase (PDE) inhibitors
- 1.4.8 Bronchodilators
- 1.4.9 Antineoplastic Agents
- 1.5 Market by Application
- 1.5.1 Global Small Animals Respiratory Diseases Treatment Market Share by Application (2019-2025)
- 1.5.2 Allergic Pneumonitis
- 1.5.3 Canine Influenza
- 1.5.4 Canine Nasal Mites
- 1.5.5 Lung Nematodes
- 1.5.6 Neoplasia Of Respiratory System
- 1.5.7 Pneumonia
- 1.5.8 Rhinitis And Sinusitis
- 1.5.9 Tonsilitis
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Small Animals Respiratory Diseases Treatment Market Size
- 2.2 Small Animals Respiratory Diseases Treatment Growth Trends by Regions
- 2.2.1 Small Animals Respiratory Diseases Treatment Market Size by Regions (2019-2025)
- 2.2.2 Small Animals Respiratory Diseases Treatment Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Small Animals Respiratory Diseases Treatment Market Size by by Players
- 3.1.1 Global Small Animals Respiratory Diseases Treatment Revenue by by Players (2014-2019)
- 3.1.2 Global Small Animals Respiratory Diseases Treatment Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Small Animals Respiratory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Small Animals Respiratory Diseases Treatment Key Players Head office and Area Served
- 3.3 Key Players Small Animals Respiratory Diseases Treatment Product/Solution/Service
- 3.4 Date of Enter into Small Animals Respiratory Diseases Treatment Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Small Animals Respiratory Diseases Treatment Market Size by Type (2014-2019)
- 4.2 Global Small Animals Respiratory Diseases Treatment Market Size by Application (2014-2019)
5 North America
- 5.1 North America Small Animals Respiratory Diseases Treatment Market Size (2014-2019)
- 5.2 Small Animals Respiratory Diseases Treatment Key Players in North America
- 5.3 North America Small Animals Respiratory Diseases Treatment Market Size by Type
- 5.4 North America Small Animals Respiratory Diseases Treatment Market Size by Application
6 Europe
- 6.1 Europe Small Animals Respiratory Diseases Treatment Market Size (2014-2019)
- 6.2 Small Animals Respiratory Diseases Treatment Key Players in Europe
- 6.3 Europe Small Animals Respiratory Diseases Treatment Market Size by Type
- 6.4 Europe Small Animals Respiratory Diseases Treatment Market Size by Application
7 China
- 7.1 China Small Animals Respiratory Diseases Treatment Market Size (2014-2019)
- 7.2 Small Animals Respiratory Diseases Treatment Key Players in China
- 7.3 China Small Animals Respiratory Diseases Treatment Market Size by Type
- 7.4 China Small Animals Respiratory Diseases Treatment Market Size by Application
8 Japan
- 8.1 Japan Small Animals Respiratory Diseases Treatment Market Size (2014-2019)
- 8.2 Small Animals Respiratory Diseases Treatment Key Players in Japan
- 8.3 Japan Small Animals Respiratory Diseases Treatment Market Size by Type
- 8.4 Japan Small Animals Respiratory Diseases Treatment Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Small Animals Respiratory Diseases Treatment Market Size (2014-2019)
- 9.2 Small Animals Respiratory Diseases Treatment Key Players in Southeast Asia
- 9.3 Southeast Asia Small Animals Respiratory Diseases Treatment Market Size by Type
- 9.4 Southeast Asia Small Animals Respiratory Diseases Treatment Market Size by Application
10 India
- 10.1 India Small Animals Respiratory Diseases Treatment Market Size (2014-2019)
- 10.2 Small Animals Respiratory Diseases Treatment Key Players in India
- 10.3 India Small Animals Respiratory Diseases Treatment Market Size by Type
- 10.4 India Small Animals Respiratory Diseases Treatment Market Size by Application
11 Central & South America
- 11.1 Central & South America Small Animals Respiratory Diseases Treatment Market Size (2014-2019)
- 11.2 Small Animals Respiratory Diseases Treatment Key Players in Central & South America
- 11.3 Central & South America Small Animals Respiratory Diseases Treatment Market Size by Type
- 11.4 Central & South America Small Animals Respiratory Diseases Treatment Market Size by Application
12 International Players Profiles
- 12.1 Zoetis, Inc.
- 12.1.1 Zoetis, Inc. Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Small Animals Respiratory Diseases Treatment Introduction
- 12.1.4 Zoetis, Inc. Revenue in Small Animals Respiratory Diseases Treatment Business (2014-2019))
- 12.1.5 Zoetis, Inc. Recent Development
- 12.2 Merck Animal Health
- 12.2.1 Merck Animal Health Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Small Animals Respiratory Diseases Treatment Introduction
- 12.2.4 Merck Animal Health Revenue in Small Animals Respiratory Diseases Treatment Business (2014-2019)
- 12.2.5 Merck Animal Health Recent Development
- 12.3 Boehringer Ingelheim GmbH
- 12.3.1 Boehringer Ingelheim GmbH Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Small Animals Respiratory Diseases Treatment Introduction
- 12.3.4 Boehringer Ingelheim GmbH Revenue in Small Animals Respiratory Diseases Treatment Business (2014-2019)
- 12.3.5 Boehringer Ingelheim GmbH Recent Development
- 12.4 Bayer AG
- 12.4.1 Bayer AG Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Small Animals Respiratory Diseases Treatment Introduction
- 12.4.4 Bayer AG Revenue in Small Animals Respiratory Diseases Treatment Business (2014-2019)
- 12.4.5 Bayer AG Recent Development
- 12.5 Ceva Animal Health
- 12.5.1 Ceva Animal Health Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Small Animals Respiratory Diseases Treatment Introduction
- 12.5.4 Ceva Animal Health Revenue in Small Animals Respiratory Diseases Treatment Business (2014-2019)
- 12.5.5 Ceva Animal Health Recent Development
- 12.6 Vetoquinol SA
- 12.6.1 Vetoquinol SA Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Small Animals Respiratory Diseases Treatment Introduction
- 12.6.4 Vetoquinol SA Revenue in Small Animals Respiratory Diseases Treatment Business (2014-2019)
- 12.6.5 Vetoquinol SA Recent Development
- 12.7 Virbac Ltd.
- 12.7.1 Virbac Ltd. Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Small Animals Respiratory Diseases Treatment Introduction
- 12.7.4 Virbac Ltd. Revenue in Small Animals Respiratory Diseases Treatment Business (2014-2019)
- 12.7.5 Virbac Ltd. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks.
In 2018, the global Small Animals Respiratory Diseases Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Small Animals Respiratory Diseases Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Animals Respiratory Diseases Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Zoetis, Inc.
Merck Animal Health
Boehringer Ingelheim GmbH
Bayer AG
Ceva Animal Health
Vetoquinol SA
Virbac Ltd.
...
Market segment by Type, the product can be split into
Anthelmintics
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Antibiotics
Antihistamines
Phosphodiesterase (PDE) inhibitors
Bronchodilators
Antineoplastic Agents
Market segment by Application, split into
Allergic Pneumonitis
Canine Influenza
Canine Nasal Mites
Lung Nematodes
Neoplasia Of Respiratory System
Pneumonia
Rhinitis And Sinusitis
Tonsilitis
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Small Animals Respiratory Diseases Treatment status, future forecast, growth opportunity, key market and key players.
To present the Small Animals Respiratory Diseases Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Small Animals Respiratory Diseases Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.